Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Abaloparatide Acetate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Radius Pharma Signs Agreement with Pharmanovia for Abaloparatide
    Radius Pharma Signs Agreement with Pharmanovia for Abaloparatide

    02 Jan 2025

    // ACCESSWIRE

    https://www.accesswire.com/962075/radius-pharmaceuticals-announces-licensing-agreement-with-pharmanovia-to-register-and-commercialize-abaloparatide-in-china-and-select-asia-pacific-territories

    ACCESSWIRE
    02 Jan 2025
    Share Share
    Radius Pharma Expands Abaloparatide Licensing Agreement
    Radius Pharma Expands Abaloparatide Licensing Agreement

    09 Dec 2024

    // ACCESSWIRE

    https://www.accesswire.com/951473/radius-pharmaceuticals-expands-abaloparatide-licensing-agreement-with-theramex-granting-additional-commercialization-rights-including-mexico-canada-south-africa-israel-and-russia

    ACCESSWIRE
    09 Dec 2024
    Share Share
    US FDA grants approval for Radius’ Tymlos for osteoporosis in men
    US FDA grants approval for Radius’ Tymlos for osteoporosis in men

    22 Dec 2022

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/fda-radius-tymlos-osteoporosis/

    PHARMACEUTICAL-TECHNOLOGY
    22 Dec 2022
    Share Share
    Teijin Pharma Receives Approval Japan for Abaloparatide Acetate for Osteoporosis
    Teijin Pharma Receives Approval Japan for Abaloparatide Acetate for Osteoporosis

    05 Sep 2022

    // PRESS RELEASE

    https://www.teijin.com/news/2022/09/05/20220905_01.pdf

    PRESS RELEASE
    05 Sep 2022
    Share Share
    Radius Health Update on Abaloparatide Transdermal System
    Radius Health Update on Abaloparatide Transdermal System

    01 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/01/2454734/31149/en/Radius-Health-Update-on-Abaloparatide-Transdermal-System.html

    GLOBENEWSWIRE
    01 Jun 2022
    Share Share
    Radius Announces Update on TYMLOS® (abaloparatide) Label
    Radius Announces Update on TYMLOS® (abaloparatide) Label

    23 Dec 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/12/23/2357391/31149/en/Radius-Announces-Update-on-TYMLOS-abaloparatide-Label.html

    GLOBENEWSWIRE
    23 Dec 2021
    Share Share